Detailed price information for Tg Therapeutics (TGTX-Q) from The Globe and Mail including charting and trades.

So, if you have learned nothing else from this story, please don’t underestimate the power of a strategically placed and ...

SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT® PNS that will be presented at the ...

Spur Therapeutics today announced that it will share updated clinical data from its Phase 1/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its Phase 3 gene therapy candidate for Type ...

AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient ...

PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative ColitisCarlsbad, CA, ...

Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its lead asset, nizubaglustat, will ...

(NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced upcoming presentations highlighting ...

This follows a promotional poster released in November last year featuring Mario and Luigi in what appeared to be the Sand Kingdom from Super Mario Odyssey. This looks to be the same location in the ...

Antidepressive effects and enhanced wakefulness were observed with OX2R activation in established animal model of major depressive disorderBOSTON and LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Centessa ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...